Sloan-Kettering Says Niro Attys Filched Gene Therapy Docs

By Kali Hays · November 4, 2016, 3:43 PM EDT

The Sloan-Kettering Institute for Cancer Research on Thursday called for sanctions against an independent biopharmaceutical company trying to get back certain rights to a type of gene therapy for a blood...

To view the full article, register now.

Documents

Case Information

Case Title

Errant Gene Therapeutics, LLC et al v. Sloan-Kettering Institute for Cancer Research

Case Number

1:15-cv-02044

Court

New York Southern

Nature of Suit

Patent

Date Filed

March 18, 2015